March Forth Announces Leadership Council
March Forth, a national initiative to increase colorectal cancer screening rates through targeted interventions, has announced its inaugural Leadership Council.
Members of the Leadership Council are powerful national and local influencers who have pledged their support for March Forth’s mission and offer invaluable insight:
- Independence Blue Cross, which serves more than 8 million people nationwide as the leading health insurance company in the Philadelphia region
- Genentech, a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious diseases
- Taiho Oncology, which works to urgently discover and develop innovative cancer treatments that address today’s unmet patient needs
- US Digestive Health, a leading gastroenterology practice on the East Coast at the forefront of the rapidly advancing science of digestive health
The March Forth Leadership Council brings together expertise and resources from a variety of stakeholders to improve colorectal cancer screening in targeted communities.
“We’re incredibly humbled by these leaders’ commitment to end colorectal cancer and to ensure that we’re doing all we can to improve screening and prevent this horrible disease both in Philadelphia and across the country,” said Michael Sapienza, Chief Executive Officer at the Colorectal Cancer Alliance, which manages March Forth.
The March Forth initiative kicked off in Philadelphia and will expand nationally, under the Leadership Council’s guidance. The goal of this initiative is to save 100,000 lives in 10 years through increased awareness, education, and screening.
Philadelphia’s large population of at-risk individuals is drastically under-screened for colorectal cancer in comparison to other major cities. With a cohesive and wide-ranging set of initiatives aimed at outreach, education, and awareness, March Forth Philadelphia will mobilize the city’s residents to eradicate colorectal cancer in their community.
The Colorectal Cancer Alliance’s national March Forth project plans to expand beyond Philadelphia in the next two years.
About the Colorectal Cancer Alliance
The Colorectal Cancer Alliance is a national nonprofit committed to ending colorectal cancer. Working with our nation of passionate allies, we diligently support the needs of patients and families, caregivers, and survivors; eagerly raise awareness of preventative screening; and continually strive to fund critical research. As allies in the struggle, we are fiercely determined to end colorectal cancer within our lifetime. For more information, please visit colorectalcancer.org.
Top resources
![Alliance executive team member Brian Cowart, left, and Marc Mason](/sites/default/files/styles/450x250/public/media/images/marc-mason-brian-cowart.png.webp?itok=00Zw9poz)
Alliance Welcomes Two Leaders to Propel Growth & Innovation
Colorectal Cancer Alliance announces key leadership appointments: Brian Cowart as Chief Development Officer and Marc Mason as Senior VP of Data Intelligence & Technology, strengthening the organization’s mission to end colorectal cancer through strategic growth and innovation.
![Tina Zeff, left, and Oluwadamilola (Dammie) Brown, M.D., executive leaders at the Colorectal Cancer Alliance](/sites/default/files/styles/450x250/public/media/images/dammie-tina.png.webp?itok=Shcnyats)
Alliance Appoints New Executive Leaders to Advance Mission
Oluwadamilola (Dammie) Brown, M.D., joins as the senior vice president of mission delivery, and Tina Zeff joins as chief operating officer of the Alliance.
![The car raffle winner is drawn at the Blue Hope Bash in Washington, D.C.](/sites/default/files/styles/450x250/public/media/images/car-raffle-ticket-drawing-2023-min.png.webp?itok=gzyHQzw0)
Watch as the 2023 Porsche Car Raffle Winner is Called
Alliance Board of Directors member Avi Benaim delighted 2023's Porsche car raffle winner with a call from the Blue Hope Bash stage, captured live in front of guests.